MHRA hires top global tech talent to transform systems behind regulation of medicines and medical devices
The Medicines and Healthcare products Regulatory Agency (MHRA) is pleased to announce the appointment of Jason Bonander as its new Chief Digital and Technology Officer (CDTO). Joining in late May 2026, the appointment of Jason strengthens the Agency’s leadership expertise in health data and technologies as it gets ready to deliver a new 5-year strategy […]
MHRA delivers its targets to increase access to medicines and reinforce UK position as a global destination for life sciences
The Medicines and Healthcare products Regulatory Agency (MHRA) met or exceeded all statutory targets to increase access to medicines and medical devices for UK patients, according to the MHRA Results and Forecast report published today (28 April). The MHRA has strengthened its position as a world-leading medicines regulator by striking new global partnerships and advancing pioneering work in clinical trials reform, AI regulation, and rare disease therapeutics […]
MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome
The Medicines and Healthcare products Regulatory Agency (MHRA) has today 10 April 2026, approved olezarsen (Tryngolza) to help treat adults with familial chylomicronemia syndrome (FCS). FCS is an inherited disease that gives rise to abnormally high levels of fats called triglycerides in the blood. This can lead to inflammation of the pancreas, causing severe pain, lasting damage to the pancreas, and can be life threatening. […]
MHRA expands AI Airlock programme with a £3.6 million funding boost over three years
The Medicines and Healthcare products Regulatory Agency (MHRA) has secured a major funding uplift to expand its pioneering AI Airlock programme, the UK’s first regulatory sandbox for Artificial Intelligence as a Medical Device (AIaMD). Following a successful second phase, the Department of Health and Social Care (DHSC) has allocated £1.2 million per year for the next three […]